Literature DB >> 33493436

SOS Brazil: science under attack.

Pedro C Hallal1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33493436      PMCID: PMC7825897          DOI: 10.1016/S0140-6736(21)00141-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   202.731


× No keyword cloud information.
As of Jan 21, 2021, Brazil ranks second in number of deaths from COVID-19 and third in number of cases seen in any single country. As a scientist, I tend not to believe in coincidence. In March, 2020, President Jair Bolsonaro referred to COVID-19 as a “gripezinha”, a little flu. In April, 2020, he declared there were signs the pandemic was coming to an end. A month later, when asked by journalists about the increasing numbers of COVID-19 cases, Bolsonaro responded “So what? What do you want me to do?” In response, the Editors suggested that “perhaps the biggest threat to Brazil's COVID-19 response is its president, Jair Bolsonaro”. More recently, Bolsonaro was, to the best of my knowledge, the only head of state worldwide to say he would not get vaccinated. He even discouraged the population from taking the vaccine by saying: “If you turn into a crocodile, it's your problem”. Although these statements are outrageous, Brazil's response to the pandemic is much worse. Testing rates are far below the world average. No national policy on contact tracing has been implemented. Social distancing has been discredited. In 4 weeks, Brazil had three ministers of health. Despite Brazilian scientists and research institutes, such as Butantan and Fiocruz, being heavily involved in the global vaccine run, supplies of syringes and needles were insufficient to start the immunisation campaign. Since the beginning of Bolsonaro's presidency in 2019, science has been attacked with budget cuts and negationism. Ricardo Galvão, director of the National Spatial Research Institute, was fired after presenting and commenting on data on deforestation. Former ministers of health, Luiz Henrique Mandetta and Nelson Teich, publicly disagreed with Bolsonaro by defending scientific recommendations to fight COVID-19. I never thought I would be next. I am the principal investigator of EPICOVID-19, the largest epidemiological study of COVID-19 in Brazil. In its first three rounds of this countrywide study, we found marked regional, ethnic, and socioeconomic disparities in the COVID-19 pandemic in Brazil, as well as a six-fold difference between official statistics and estimates on the real number of infected people. These findings were not well received by the ministry of health, and funding for the study was discontinued in July, 2020. Fortunately, EPICOVID-19 has received funding from other institutions and continued to provide information on the burden of COVID-19 in Brazil. In 2020, I was summoned to Brasília on three separate occasions for meetings with the ministry of health. Four days after my last visit to Brasília, in December, 2020, I started presenting with COVID-19 symptoms. My severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was revealed to the public by the media, and I was accused of hypocrisy and a “do as I say, not as I do” attitude. On Jan 11, 2021, in a radio interview, I was criticised by a congressman and by a journalist: the reason being that if I had been infected with SARS-CoV-2, it meant I did not follow the very advice I disseminate. On Jan 14, 2021, Bolsonaro tweeted the link to the specific segment of the radio interview in which my infection was mentioned. Coincidentally or not, Bolsonaro's attack occurred exactly when the pandemic reached unprecedented numbers in Brazil. Manaus, in the Amazon region, is experiencing chaos as oxygen supplies are being depleted. The minister of health flew to Manaus and, after a 3-day visit, announced the city would be supplied with chloroquine, ivermectin, and other drugs to fight the situation. At the same time, politicians, businessmen, and other supporters of Bolsonaro were fighting against an announced (and urgently needed) lockdown in Manaus. Unbelievably, on Jan 16, 2021, a publication from the ministry of health was flagged by Twitter as violating its publication rules for disseminating misleading and potentially harmful information related to COVID-19. Brazil's tragic COVID-19 policy comes with a price. With 211 million people, the Brazilian population represents 2·7% of the world's population. If Brazil accounted for 2·7% of global COVID-19 deaths (ie, performing as the global average in fighting the pandemic), 56 311 people would have died. However, by Jan 21, 2021, 212 893 people have died from COVID-19. In other words, 156 582 lives were lost in the country because of underperformance. Attacking scientists will definitely not help solve the problem.
  15 in total

Review 1.  An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic.

Authors:  Julian W Tang; Miguela A Caniza; Mike Dinn; Dominic E Dwyer; Jean-Michel Heraud; Lance C Jennings; Jen Kok; Kin On Kwok; Yuguo Li; Tze Ping Loh; Linsey C Marr; Eva Megumi Nara; Nelun Perera; Reiko Saito; Carlos Santillan-Salas; Sheena Sullivan; Matt Warner; Aripuanã Watanabe; Sabeen Khurshid Zaidi
Journal:  Interface Focus       Date:  2022-02-11       Impact factor: 3.906

2.  The COVID-19 pandemic in Brazilian pregnant and postpartum women: results from the REBRACO prospective cohort study.

Authors:  Renato T Souza; Jose G Cecatti; Rodolfo C Pacagnella; Carolina C Ribeiro-Do-Valle; Adriana G Luz; Giuliane J Lajos; Guilherme M Nobrega; Thayna B Griggio; Charles M Charles; Silvana F Bento; Carla Silveira; Fernanda G Surita; Maria J Miele; Ricardo P Tedesco; Karayna G Fernandes; Sérgio H A Martins-Costa; Frederico J A Peret; Francisco E Feitosa; Rosiane Mattar; Evelyn Traina; Edson V Cunha Filho; Janete Vettorazzi; Samira M Haddad; Carla B Andreucci; José P Guida; Mario D Correa Junior; Marcos A B Dias; Leandro De Oliveira; Elias F Melo Junior; Marília G Q Luz; Maria Laura Costa
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

3.  COVID-19, vaccine hesitancy and child vaccination: Challenges from Brazil.

Authors:  Michelle Fernandez; Gustavo Matta; Ester Paiva
Journal:  Lancet Reg Health Am       Date:  2022-04-01

Review 4.  Science's Response to CoVID-19.

Authors:  Marcus J C Long; Yimon Aye
Journal:  ChemMedChem       Date:  2021-06-22       Impact factor: 3.540

5.  SARS-CoV-2 (COVID-19) pandemic and a possible impact in the future of menstrual cycle research.

Authors:  Raul Cosme Ramos Prado; Rodrigo Silveira; Ricardo Yukio Asano
Journal:  Health Sci Rep       Date:  2021-05-03

6.  The impact of the COVID-19 pandemic in the frontline health workforce: Perceptions of vulnerability of Brazil's community health workers.

Authors:  Gabriela Lotta; João Nunes; Michelle Fernandez; Marcela Garcia Correa
Journal:  Health Policy Open       Date:  2022-01-05

7.  The COVID-19 epidemic in Brazil: how statistics education may contribute to unravel the reality behind the charts.

Authors:  Alexandre Sousa da Silva; Maria Tereza Serrano Barbosa; Luciane de Souza Velasque; Davi da Silveira Barroso Alves; Marcos Nascimento Magalhães
Journal:  Educ Stud Math       Date:  2021-10-14

8.  Comparison of 30-day case-fatality rate between dialysis and transplant Covid-19 patients: a propensity score matched cohort study.

Authors:  Tainá Veras de Sandes-Freitas; Luís Gustavo Modelli de Andrade; Jocemir Ronaldo Lugon; Ricardo Sesso; Lucio Roberto Requião Moura; Marina Pontello Cristelli; José Osmar Medina-Pestana
Journal:  J Nephrol       Date:  2021-10-22       Impact factor: 3.902

9.  One Year of Coronavirus Disease 2019 (COVID-19) in Brazil: A Political and Social Overview.

Authors:  Matheus Negri Boschiero; Camila Vantini Capasso Palamim; Manoela Marques Ortega; Renan Marrichi Mauch; Fernando Augusto Lima Marson
Journal:  Ann Glob Health       Date:  2021-05-18       Impact factor: 2.462

10.  HIV/Aids and COVID-19 in Brazil: in four decades, two antithetical approaches to face serious pandemics.

Authors:  Bernardo Galvão-Castro; Maria Fernanda Rios Grassi; Euclides Ayres de Castilho; Dirceu Bartolomeu Greco
Journal:  Mem Inst Oswaldo Cruz       Date:  2021-06-21       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.